Biosceptre International Limited news
The funding, drawn from Norcliffe Capital in Europe and Jungle Capital in Australia, will help Biosceptre push it’s unique lead program towards clinical trials.
“We are really pleased by this fund raise as it reaffirms confidence in our ground-breaking nfP2X7-targeted therapies, and the drastic difference they could make to the lives of thousands of cancer patients, world-wide,” explained said Mr Gavin Currie, CEO of Biosceptre.
“The funding will
The new laboratory, established with the support of Biosceptre, will enable BIF to fast-track analytical and process development capabilities and support the Australian bio-processing sector at a critical time in the sector’s growth.
BIF is the only facility of its kind in an Australian University and is the NSW node of the National Biologics Facility in the National Collaborative Infrastructure Research Strategy funded Therapeutics Innovation Australia. The Facility also
Biosceptre (Aust) P/L has today announced an agreement with The University of Sydney and Children’s Medical Research Institute (CMRI) to establish a new research program on CAR-T cell immunotherapy, at CMRI’s premises in Westmead, Western Sydney.
Biosceptre is developing anti-cancer therapies – in particular, targeted therapeutics and immune-oncology products targeting most types of cancers, with the goal of bringing novel treatments to patients suffering from a wide
Biosceptre is pleased to announce that an agreement has been signed with pre-clinical CAR T development company, Carina Biotech, that will see the advancement of a promising cancer immunotherapy.
Biosceptre, a biopharmaceutical company developing targeted therapeutics and immune-oncology products, has acquired the exclusive rights to Carina Biotech’s nfP2X7-targeted CAR-T cells and associated intellectual property, which has shown encouraging cancer-killing capacity a
Upon invitation from our lead investor Tuspark S&T, Biosceptre recently participated in the Ministry of Education of the People’s Republic of China’s, 4th Annual Internet Plus Innovation and Entrepreneurship Competition. The competition was held by an affiliated institute; the Xiamen University in Fujian, China, in the third week of October 2018.
It has become the country’s largest and most influential platform for promoting innovation and entrepreneurship, and a